16 results
424B5
MDGL
Madrigal Pharmaceuticals, Inc.
2 Oct 23
Prospectus supplement for primary offering
5:10pm
are increasing in their frequency, levels of persistence, sophistication and intensity, and they are being conducted by increasingly sophisticated
424B5
MDGL
Madrigal Pharmaceuticals, Inc.
28 Sep 23
Prospectus supplement for primary offering
4:01pm
and intensity, and they are being conducted by increasingly sophisticated and organized groups and individuals with a wide range of motives and expertise
8-K
EX-99.1
mehbmw
27 Feb 19
Madrigal Pharmaceuticals Reports 2018 Fourth Quarter
8:51am
8-K
EX-99.1
nonunb
6 Nov 18
Madrigal Pharmaceuticals Reports 2018 Third Quarter
8:50am
8-K
EX-99.1
a37fluz35uhb48nbc6p
7 Aug 18
Madrigal Pharmaceuticals Reports 2018 Second Quarter Financial Results and Reviews Key Clinical Achievements
8:51am
8-K
EX-99.1
lwdp9l
31 May 18
Other Events
7:00am
8-K
EX-99.1
wp6w szmrffn9dc
8 May 18
Madrigal Pharmaceuticals Reports 2018 First Quarter
8:50am
- Prev
- 1
- Next